ArticleVaccines2022

Risk of Infection and Duration of Protection after the Booster Dose of the Anti-SARS-CoV-2 Vaccine BNT162b2 among Healthcare Workers in a Large Teaching Hospital in Italy: Results of an Observational Study.

Domenico Pascucci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.